drug

WVE-004

1 story · latest Sep 9, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Wave Life Sciences, Inc.

Timeline

Wave posts results for terminated WVE-004 OLE study in C9orf72 ALS/FTD

Sep 9Trial updateWave Life Sciences, Inc.WVE-004

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.